# OnKure Therapeutics, Inc.: Form SC 13D/A, filed May 8, 2024

- Company: [OnKure Therapeutics, Inc.](/companies/okur.md) (CIK 1637715)
- Form: SC 13D/A
- Filed: 2024-05-08
- Accepted by EDGAR: May 8, 2024, 16:33 ET
- Period: not reported
- Accession: 0001072613-24-000437
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1637715/000107261324000437/nea15-reneo_18834.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1637715/000107261324000437/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1637715/000107261324000437/nea15-reneo_18834.htm

Filed May 8, 2024.
Source: SEC EDGAR, the filing index for accession 0001072613-24-000437. Last ingested by Listed: Nov 4, 2026, 17:06 ET. No prices; not investment advice.